Impact of treatment interval between neoadjuvant immunochemotherapy and surgery in lung squamous cell carcinoma.

MLA

Gu, Chen, et al. “Impact of Treatment Interval between Neoadjuvant Immunochemotherapy and Surgery in Lung Squamous Cell Carcinoma.” BMC Cancer, vol. 24, no. 1, May 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12885-024-12333-3.

APA

Gu, C., Teng, X., sun, X., Liu, J., Zhu, Z., Zhang, L., Wu, Z., Zou, R., Pang, J., & Lyu, X. (2024). Impact of treatment interval between neoadjuvant immunochemotherapy and surgery in lung squamous cell carcinoma. BMC Cancer, 24(1), 1–9. https://doi.org/10.1186/s12885-024-12333-3

Chicago

Gu, Chen, Xiao Teng, Xuqi sun, Jiacong Liu, Ziyue Zhu, Lichen Zhang, Zhigang Wu, Rui Zou, Jinghua Pang, and Xiayi Lyu. 2024. “Impact of Treatment Interval between Neoadjuvant Immunochemotherapy and Surgery in Lung Squamous Cell Carcinoma.” BMC Cancer 24 (1): 1–9. doi:10.1186/s12885-024-12333-3.